MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · IEX Real-Time Price · USD

40.15

-1.65 (-3.95%)

At close: Jul 2, 2024, 4:00 PM

40.00

-0.15 (-0.37%)

After-hours: Jul 2, 2024, 7:27 PM EDT

MLTX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	2,524	3,771	553	146	168
Market Cap Growth	184.67%	581.49%	277.92%	-13.02%	-
Enterprise Value	1,981	3,264	482	153	167
PE Ratio	-	-85.55	-8.58	-2.73	-1853.11
PB Ratio	4.65	7.61	11.32	-12.57	-66.90
P/FCF Ratio	-65.23	-87.57	-9.90	-4.16	-531.53
P/OCF Ratio	-65.89	-88.16	-9.90	-4.16	-531.53
EV/EBITDA Ratio	-58.39	-74.23	-7.47	-2.86	-1839.04
EV/EBIT Ratio	-58.35	-74.20	-7.47	-2.86	-1839.04
EV/FCF Ratio	-54.18	-75.79	-8.61	-4.35	-527.50
Debt / Equity Ratio	0.01	0.01	0.01	-1.29	-0.02
Debt / EBITDA Ratio	-0.08	-0.08	0.00	-0.28	-0.64
Debt / FCF Ratio	-0.07	-0.09	-0.01	-0.43	-0.18
Quick Ratio	61.56	51.38	9.44	0.39	10.67
Current Ratio	62.13	51.59	9.98	0.46	12.93
Return on Equity (ROE)	-9.40%	-12.10%	-181.20%	3310.30%	-
Return on Assets (ROA)	-8.70%	-11.00%	-93.60%	-59.80%	-
Return on Capital (ROIC)	-11.17%	-10.84%	-132.29%	-1596.93%	4.30%
Earnings Yield	-1.82%	-1.17%	-11.66%	-36.64%	-0.05%
FCF Yield	-1.95%	-1.14%	-10.10%	-24.06%	-0.19%
Buyback Yield / Dilution	-60.35%	-67.30%	87.40%	-2510.73%	-
Total Shareholder Return	-60.35%	-67.30%	87.40%	-2510.73%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).